October 21, 2015
RegMed’s mid-day: Athersys (ATHX) sets a domino effect as the sector suffers
October 20, 2015
RegMed’s close: same story, different day, traders are in until they're out
October 10, 2015
RegMed’s close: I worry as cell and gene therapy scurry for cover
October 6, 2015
Osiris (OSIR) Initiates P3 trial for treatment of Chronic Diabetic Foot Wounds – on dips, BUY
September 30, 2015
Higher open expected; RegMed, end the month and quarter so we can move on
September 29, 2015
RegMed’s mid-day: touchy and sensitive
September 29, 2015
Higher open expected; RegMed, finding the way back – now is the time to selectively bottom fish!
September 28, 2015
RegMed’s mid-day: serving from a Lazy Susan, a turntable, rotating tray of fear, uncertainty and weakness
September 28, 2015
Opexa Therapeutics (OPXA), a 1-for-8 reverse stock split of its common stock to maintain NASDAQ listing
September 28, 2015
Lower open expected; RegMed, far too many sector companies have suffered
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.